Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Published in: Osteoporosis International 12/2005

01-12-2005 | Letter

Is there an association between high heparanase level and osteoporosis risk in breast cancer patients without clinical evidence of bone metastases?

Authors: Kadri Altundag, Ozden Altundag, Mauricio Z. Baptista, Selahattin Turen, Mustafa A. Atik

Published in: Osteoporosis International | Issue 12/2005

Login to get access

Excerpt

To the Editor, …
Literature
1.
van Poznak C, Sauter NP (2005) Clinical management of osteoporosis in women with a history of breast carcinoma. Cancer 104:443–456CrossRefPubMed
2.
Kanis JA, McCloskey EV, Powles T, Kanis JA, McCloskey EV, Powles T, Paterson AH, Ashley S, Spector T (1999) A high incidence of vertebral fracture in women with breast cancer. Br J Cancer 79:1179–1181CrossRefPubMed
3.
Taube T, Elomaa I, Blomqvist C, Beneton MNC, Kanis JA (1994) Histomorphometric evidence for osteoclast mediated bone resorption in metastatic breast cancer. Bone 15:161–166CrossRefPubMed
4.
Orloff JJ, Wu TL, Stewart AF (1989) Parathyroid hormone-like proteins: biochemical responses and receptor interactions. Endocr Rev 10:476–495PubMed
5.
Powell GJ, Southby J, Danks JA et al (1991) Localisation of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res 51:3059–3061PubMed
6.
Kelly T, Suva LJ, Huang Y et al (2005) Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases. Cancer Res 65:5778–5784CrossRefPubMed
Metadata
Title
Is there an association between high heparanase level and osteoporosis risk in breast cancer patients without clinical evidence of bone metastases?
Authors
Kadri Altundag
Ozden Altundag
Mauricio Z. Baptista
Selahattin Turen
Mustafa A. Atik
Publication date
01-12-2005
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 12/2005
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-005-2034-x

Other articles of this Issue 12/2005

Osteoporosis International 12/2005 Go to the issue

Original Article

Metacarpal index and bone mineral density in healthy African-American women

Original Article

Ultrasound of the calcaneus and bone mineral density differs in older black and white women but is not impacted by current physical activity

Original Article

Association of quantitative heel ultrasound with history of osteoporotic fractures in elderly men: The ESOPO study

Original Article

Knowledge about osteoporosis and its related factors among public health nurses in Taiwan

Original Article

Green tea catechin enhances osteogenesis in a bone marrow mesenchymal stem cell line

Original Article

Reduction of pain and fracture incidence after kyphoplasty: 1-year outcomes of a prospective controlled trial of patients with primary osteoporosis